COX-1, COX-2 and the topical effect in NSAID-induced enteropathy

By Hotz-Behofsits C. M.   Walley M. J. M.   Simpson R.   Bjarnason I. T.  

Inflammopharmacology, Vol. 11, Iss. 4-6, 2003-12 ,pp. : 363-370

VSP

Access to resources Recommend Favorite

NSAID-related CV risks not defined by COX-2 selectivity alone

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Towards understanding: COX-2s and cardiovascular disorders

By  

Reactions Weekly, Vol. 1, Iss. 1036, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Concomitant Use of Gastroprotective Drugs among Elderly NSAID/COX-2 Selective Inhibitor Users: A Nationwide Register-Based Study

By Johnell Kristina   Fastbom Johan  

Clinical Drug Investigation, Vol. 28, Iss. 11, 2008-01 ,pp. : 687-695

Adis International

Access to resources Recommend Favorite

Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities

By Bennett A.   Villa G.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 277-286

Informa Healthcare

Access to resources Recommend Favorite